International Journal of Clinical & Medical Microbiology Volume 2 (2017), Article ID 2:IJCMM-123, 4 pages
https://doi.org/10.15344/2456-4028/2017/123
https://doi.org/10.15344/2456-4028/2017/123
Research Article
Enterococcus faecium L-3 in Eradication of Helicobacter pylori: In-vivo and In-vitro
References
- Malfertheiner P, Megraud F, O’Morain CA, Gisbert JP, Kuipers EJ, et al. (2017) Management of Helicobacter pylori infection-the Maastricht V/ Florence Consensus Report. Gut 66: 6-30 [CrossRef] [Google Scholar] [PubMed]
- Coconnier MH, Liévin V, Hemery E, Servin AL (1998) Antagonistic activity against Helicobacter infection in vitro and in vivo by the human Lactobacillus acidophilus strain LB. Appl Environ Microbiol 64: 4573-4580 [Google Scholar] [PubMed]
- O'Connor HJ (1994) Eradication of Helicobacter pylori. European journal of gastroenterology & hepatology 6: S113-S119
- Lesbros-Pantoflickova D, Corthésy-Theulaz I, Blum AL (2007) Helicobacter pylori and probiotics. The Journal of nutrition 137: 812S-818S [CrossRef] [Google Scholar]
- Gotteland M, Brunser O, Cruchet S (2006) Systematic review: are probiotics useful in controlling gastric colonization by Helicobacter pylori? Aliment Pharmacol Ther 23: 1077-1086 [CrossRef] [Google Scholar] [PubMed]
- Szajewska H, Horvath A, Piwowarczyk A (2010) Meta-analysis: the effects of Saccharomyces boulardii supplementation on Helicobacter pylori eradication rates and side effects during treatment. Aliment Pharmacol Ther 32: 1069-1079 [CrossRef] [Google Scholar] [PubMed]
- Baryshnikova NV (2011) Helicobacter pylori infection and colon dysbiosis. Lambert LAP Lambert Academic Publishing, pp 50-130
- Rustamov M, Baryshnikova N, Rustamova L (2016) Helicobacter 21 Suppl 1: 149
- Baryshnikova NV (2012) Helicobacter pylori-associated gastroenterological diseases: genetic features and probiotic treatment. Beneficial Microbes 3: 157-161 [CrossRef] [Google Scholar] [PubMed]
- Kim TS, Hur JW, Yu MA, Cheigh CI, Kim KN, et al. (2003) Antagonism of Helicobacter pylori by bacteriocins of lactic acid bacteria. J Food Prot 66: 3-12 [CrossRef] [Google Scholar] [PubMed]
- Ermolenko EI, Chernysh AI, Martsinkovskaia IV, Suvorov AN (2006) Influence of probiotic enterococci on the growth of Streptococcus agalactiae. Zh Mikrobiol Epidemiol Immunobiol 5: 73-77 [Google Scholar] [PubMed]
- Ermolenko EI (2009) Bacteriocins of enterococci, problems and perspectives of using. Vestn of Saint-Petrsburg university 11: 78-93
- Yermolenko E, Kolobov A, Chernysh A, Suvorov A (2011) Influence of synthetic peptide inductors on antibacterial activity of enterococci. Beneficial Microbes 2: 9-13 [CrossRef] [Google Scholar] [PubMed]
- Karaseva A, Tsapieva A, Pachebat J, Suvorov A (2016) Draft genome sequence of probiotic Enterococcus faecium strain L-3. Genome announcements. Genome Announc 4: e01622-15 [CrossRef] [Google Scholar] [PubMed]
- Ermolenko E (2011) Lactic acid bacteria Labert academic Publishing, Deutchland Labert, Deutchland: 283
- Suvorov AN, Simanenkov VI, Zakharova NV, Baryshnikova NV (2013) Efficacy of Enterococcus faecium L3 in therapy of Helicobacter pylori infection. International Scientific conference on bacteriocins and antimicrobial peptides, 28
- Suvorov A (2013) Gut microbiota, probiotics, and human health. Biosci Microbiota Food Health 32: 81-91 [CrossRef] [Google Scholar] [PubMed]
- Tsapieva A, Duplik N, Suvorov A (2011) Structure of plantaricin locus of Lactobacillus plantarum 8Р- А3. Benef Microbes 2: 255-261 [CrossRef] [Google Scholar] [PubMed]
- Zhebrun AB, Svarval' AV, Balabash OA, Ferman RS (2013) Helicobacter pylori population characteristic in patients with diseases of gastrointestinal tract. Zh Mikrobiol Epidemiol Immunobiol 2: 90-96 [Google Scholar] [PubMed]
- Sainsus N, Cattori V, Lepadatu C, Hofmann-Lehmann R (2008) Liquid culture medium for the rapid cultivation of Helicobacter pylori from biopsy specimens. Eur J Clin Microbiol Infect Dis 27: 1209-1217 [CrossRef] [Google Scholar] [PubMed]
- Suvorov A, Simanenkov V, Gromova L, Kolodjieva V, Tsapieva A, et al. (2011) Enterococci as probiotics or autoprobiotics. Prebiotics and probiotics potential for human health, Ivanova I (ed), Paisi Hilendarski, Sofia, 104-112
- Ermolenko EI, Isakov VA, Zhdan-Pushkina S, Tets VV (2003) Quantitative characterization of antagonistic activity of lactobacilli. Zhurnal mikrobiologii, epidemiologii, i immunobiologii 5: 94-98 [Google Scholar] [PubMed]